Feasibility of computerized working memory training in individuals with Huntington disease

PLoS One. 2017 Apr 28;12(4):e0176429. doi: 10.1371/journal.pone.0176429. eCollection 2017.

Abstract

Objectives: Huntington disease (HD) is associated with a variety of cognitive deficits, with prominent difficulties in working memory (WM). WM deficits are notably compromised in early-onset and prodromal HD patients. This study aimed to determine the feasibility of a computerized WM training program (Cogmed QM), novel to the HD population.

Methods: Nine patients, aged 26-62, with early stage HD underwent a 25-session (5 days/week for 5 weeks) WM training program (Cogmed QM). Training exercises involved the manipulation and storage of verbal and visuospatial information, with difficulty adapted as a function of individual performance. Neuropsychological testing was conducted before and after training, and performance on criterion WM measures (Digit Span and Spatial Span), near-transfer WM measures (Symbol Span and Auditory WM), and control measures were evaluated. Post-training interviews about patient experience were thematically analyzed using NVivo software.

Results: Seven of nine patients demonstrated adherence to the training and completed all sessions within the recommended timeframe of 5 weeks. All adherent patients showed improvement on the Cogmed tasks as defined by the Improvement Index (M = 22.17, SD = 8.84, range = 13-36). All adherent patients reported that they found training helpful (n = 7), and almost all felt that their memory improved (n = 6). Participants also expressed that the training was difficult, sometimes frustrating, and time consuming.

Conclusions: This pilot study provides support for feasibility of computerized WM training in early-stage patients with HD. Results suggest that HD patients perceive benefits of intensive WM training, though a full-scale and controlled intervention project is needed to understand the size of the effect and reliability of changes over time.

Trial registration: ClinicalTrials.gov, Registry number NCT02926820.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Feasibility Studies
  • Female
  • Humans
  • Huntington Disease / physiopathology*
  • Huntington Disease / therapy*
  • Interviews as Topic
  • Male
  • Memory, Short-Term*
  • Middle Aged
  • Neuropsychological Tests
  • Patient Compliance

Associated data

  • ClinicalTrials.gov/NCT02926820

Grants and funding

This study was funded by the North York General Hospital Exploration Fund (http://www.nygh.on.ca/Default.aspx?cid=2392), awarded to C.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.